{"entity":{"type":"insider","cik":"0001255927","url":"/insider/0001255927","json_url":"/insider/0001255927.json","name":"KANIA EDWIN M JR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":126,"n_filings":40,"first":"2004-12-06","last":"2021-11-30","span_basis":"filed_date"},"name_variants":[{"name":"KANIA EDWIN M JR","source":"filing","n_filings":40,"first_seen":"2004-12-06","last_seen":"2021-11-30"}],"transactions":[{"id":5238331,"accession":"0000899243-21-046299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046299","line_url":"/filing/0000899243-21-046299","is_derivative":false,"issuer_cik":"0001255927","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001255927","owner_cik":"0001255927","owner_name":"KANIA EDWIN M JR","owner_display_name":"KANIA EDWIN M JR","owner_url":"/insider/0001255927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":22.5621534,"price_display":"22.56","price_state":"stated","total_value":2256215.34,"total_display":"2,256,215.34","total_whole":"2,256,215","shares_owned_after":302893.0,"shares_owned_after_display":"302,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-11-30","scope":"insider","n_lines":2},{"id":2327715,"accession":"0000899243-20-001179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-001179","line_url":"/filing/0000899243-20-001179#line-2","is_derivative":false,"issuer_cik":"0001255927","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001255927","owner_cik":"0001255927","owner_name":"KANIA EDWIN M JR","owner_display_name":"KANIA EDWIN M JR","owner_url":"/insider/0001255927","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117625.0,"shares_display":"117,625","price_per_share":20.0114,"price_display":"20.01","price_state":"stated","total_value":2353840.925,"total_display":"2,353,840.92","total_whole":"2,353,841","shares_owned_after":23847.0,"shares_owned_after_display":"23,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-14","filed_date":"2020-01-14","scope":"insider"},{"id":2327711,"accession":"0000899243-20-001179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-001179","line_url":"/filing/0000899243-20-001179#line-1","is_derivative":false,"issuer_cik":"0001255927","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001255927","owner_cik":"0001255927","owner_name":"KANIA EDWIN M JR","owner_display_name":"KANIA EDWIN M JR","owner_url":"/insider/0001255927","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357375.0,"shares_display":"357,375","price_per_share":20.3427,"price_display":"20.34","price_state":"stated","total_value":7269972.4125,"total_display":"7,269,972.41","total_whole":"7,269,972","shares_owned_after":141472.0,"shares_owned_after_display":"141,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-10","filed_date":"2020-01-14","scope":"insider"},{"id":7831390,"accession":"0000899243-19-028975","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-19-028975","line_url":"/filing/0000899243-19-028975","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"KANIA EDWIN M JR; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV-Rx, L.P.; AFEYAN NOUBAR","owner_display_name":"KANIA EDWIN M JR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":238301.0,"shares_display":"238,301","price_per_share":18.6548,"price_display":"18.65","price_state":"stated","total_value":4445457.4948,"total_display":"4,445,457.49","total_whole":"4,445,457","shares_owned_after":31216399.0,"shares_owned_after_display":"31,216,399","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-11","scope":"insider","n_lines":2},{"id":8091965,"accession":"0000899243-19-028978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-028978","line_url":"/filing/0000899243-19-028978#line-1","is_derivative":false,"issuer_cik":"0001255927","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001255927","owner_cik":"0001255927","owner_name":"KANIA EDWIN M JR","owner_display_name":"KANIA EDWIN M JR","owner_url":"/insider/0001255927","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":18.8084,"price_display":"18.81","price_state":"stated","total_value":1880840.0,"total_display":"1,880,840.00","total_whole":"1,880,840","shares_owned_after":498847.0,"shares_owned_after_display":"498,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider"},{"id":7831384,"accession":"0000899243-19-028975","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-19-028975","line_url":"/filing/0000899243-19-028975","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"KANIA EDWIN M JR; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV-Rx, L.P.; AFEYAN NOUBAR","owner_display_name":"KANIA EDWIN M JR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25417.0,"shares_display":"25,417","price_per_share":18.9586,"price_display":"18.96","price_state":"stated","total_value":481870.7362,"total_display":"481,870.74","total_whole":"481,871","shares_owned_after":31416334.0,"shares_owned_after_display":"31,416,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider","n_lines":2},{"id":7831377,"accession":"0000899243-19-028975","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-19-028975","line_url":"/filing/0000899243-19-028975","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Moderna, Inc.","issuer_ticker":"MRNA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"KANIA EDWIN M JR; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV-Rx, L.P.; AFEYAN NOUBAR","owner_display_name":"KANIA EDWIN M JR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":172137.0,"shares_display":"172,137","price_per_share":18.994216099966888,"price_display":"18.99","price_state":"stated","total_value":3269607.3768,"total_display":"3,269,607.38","total_whole":"3,269,607","shares_owned_after":31437659.0,"shares_owned_after_display":"31,437,659","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider","n_lines":2},{"id":8667371,"accession":"0001104659-19-029735","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001104659-19-029735","line_url":"/filing/0001104659-19-029735#line-12","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; Flagship Ventures Opportunities Fund I, L.P.; AFEYAN NOUBAR; Flagship Ventures Fund 2007, L.P.; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship VentureLabs IV, LLC; KANIA EDWIN M JR","owner_display_name":"Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":986023.0,"shares_owned_after_display":"986,023","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-15","scope":"insider"},{"id":8375967,"accession":"0000899243-19-012293","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-19-012293","line_url":"/filing/0000899243-19-012293#line-8","is_derivative":false,"issuer_cik":"0001255927","issuer_name":"TransMedics Group, Inc.","issuer_ticker":"TMDX","issuer_name_source":null,"issuer_url":"/issuer/0001255927","owner_cik":"0001255927","owner_name":"KANIA EDWIN M JR","owner_display_name":"KANIA EDWIN M JR","owner_url":"/insider/0001255927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33333.0,"shares_display":"33,333","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":533328.0,"total_display":"533,328.00","total_whole":"533,328","shares_owned_after":33333.0,"shares_owned_after_display":"33,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-06","filed_date":"2019-05-06","scope":"insider"},{"id":6007977,"accession":"0000899243-18-013013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-013013","line_url":"/filing/0000899243-18-013013#line-2","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship V VentureLabs Rx Fund, L.P.; KANIA EDWIN M JR; Flagship Ventures Opportunities Fund I General Partner LLC; Flagship VentureLabs V LLC; Flagship Ventures Fund V General Partner LLC; Nutritional Health Disruptive Innovation Fund, L.P.; Flagship Ventures Fund V, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Nutritional Health Side Fund, L.P.","owner_display_name":"Flagship V VentureLabs Rx Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":281250.0,"shares_display":"281,250","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":4500000.0,"total_display":"4,500,000.00","total_whole":"4,500,000","shares_owned_after":18233403.0,"shares_owned_after_display":"18,233,403","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-11","filed_date":"2018-05-15","scope":"insider"},{"id":4441915,"accession":"0001012975-17-000439","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-17-000439","line_url":"/filing/0001012975-17-000439#line-1","is_derivative":false,"issuer_cik":"0001255927","issuer_name":"SELECTA BIOSCIENCES INC","issuer_ticker":"SELB","issuer_name_source":null,"issuer_url":"/issuer/0001255927","owner_cik":"0001255927","owner_name":"KANIA EDWIN M JR","owner_display_name":"KANIA EDWIN M JR","owner_url":"/insider/0001255927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":266795.0,"shares_display":"266,795","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":3735130.0,"total_display":"3,735,130.00","total_whole":"3,735,130","shares_owned_after":560067.0,"shares_owned_after_display":"560,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-16","scope":"insider"},{"id":2163644,"accession":"0001012975-16-001507","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001012975-16-001507","line_url":"/filing/0001012975-16-001507","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV-Rx, L.P.; Flagship Ventures Fund IV, L.P.","owner_display_name":"Flagship Ventures Fund 2007, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67071.0,"shares_display":"67,071","price_per_share":3.1139553607371293,"price_display":"3.11","price_state":"stated","total_value":208856.1,"total_display":"208,856.10","total_whole":"208,856","shares_owned_after":426885.0,"shares_owned_after_display":"426,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-23","filed_date":"2016-09-26","scope":"insider","n_lines":4},{"id":2163624,"accession":"0001012975-16-001507","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-16-001507","line_url":"/filing/0001012975-16-001507","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV-Rx, L.P.; Flagship Ventures Fund IV, L.P.","owner_display_name":"Flagship Ventures Fund 2007, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":376351.0,"shares_display":"376,351","price_per_share":3.1737436860802815,"price_display":"3.17","price_state":"stated","total_value":1194441.61,"total_display":"1,194,441.61","total_whole":"1,194,442","shares_owned_after":480545.0,"shares_owned_after_display":"480,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-22","filed_date":"2016-09-26","scope":"insider","n_lines":4},{"id":2588132,"accession":"0001012975-16-001505","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001012975-16-001505","line_url":"/filing/0001012975-16-001505","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR","owner_display_name":"Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":322723.0,"shares_display":"322,723","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":1210211.25,"total_display":"1,210,211.25","total_whole":"1,210,211","shares_owned_after":781643.0,"shares_owned_after_display":"781,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-21","filed_date":"2016-09-21","scope":"insider","n_lines":2},{"id":2588123,"accession":"0001012975-16-001505","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-16-001505","line_url":"/filing/0001012975-16-001505","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR","owner_display_name":"Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53917.0,"shares_display":"53,917","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":182778.63,"total_display":"182,778.63","total_whole":"182,779","shares_owned_after":1039857.0,"shares_owned_after_display":"1,039,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-21","scope":"insider","n_lines":2},{"id":2588113,"accession":"0001012975-16-001505","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-001505","line_url":"/filing/0001012975-16-001505","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV-Rx, L.P.; KANIA EDWIN M JR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund 2007, L.P.; AFEYAN NOUBAR","owner_display_name":"Flagship Ventures Fund IV-Rx, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9700.0,"shares_display":"9,700","price_per_share":3.31,"price_display":"3.31","price_state":"stated","total_value":32107.0,"total_display":"32,107.00","total_whole":"32,107","shares_owned_after":1082996.0,"shares_owned_after_display":"1,082,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-19","filed_date":"2016-09-21","scope":"insider","n_lines":2},{"id":3161028,"accession":"0001012975-16-001503","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-16-001503","line_url":"/filing/0001012975-16-001503","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund 2007, L.P.; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; KANIA EDWIN M JR; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_display_name":"AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2681.0,"shares_display":"2,681","price_per_share":4.16,"price_display":"4.16","price_state":"stated","total_value":11152.96,"total_display":"11,152.96","total_whole":"11,153","shares_owned_after":1090757.0,"shares_owned_after_display":"1,090,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-16","scope":"insider","n_lines":2},{"id":3161021,"accession":"0001012975-16-001503","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-001503","line_url":"/filing/0001012975-16-001503","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"AFEYAN NOUBAR; Flagship Ventures Fund 2007, L.P.; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; KANIA EDWIN M JR; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_display_name":"AFEYAN NOUBAR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44011.0,"shares_display":"44,011","price_per_share":4.18,"price_display":"4.18","price_state":"stated","total_value":183965.98,"total_display":"183,965.98","total_whole":"183,966","shares_owned_after":1092902.0,"shares_owned_after_display":"1,092,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-14","filed_date":"2016-09-16","scope":"insider","n_lines":2},{"id":3161011,"accession":"0001012975-16-001495","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001012975-16-001495","line_url":"/filing/0001012975-16-001495","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"KANIA EDWIN M JR; AFEYAN NOUBAR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund 2007, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_display_name":"KANIA EDWIN M JR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93727.0,"shares_display":"93,727","price_per_share":4.51,"price_display":"4.51","price_state":"stated","total_value":422708.77,"total_display":"422,708.77","total_whole":"422,709","shares_owned_after":1833802.0,"shares_owned_after_display":"1,833,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-07","filed_date":"2016-09-08","scope":"insider","n_lines":3},{"id":3161000,"accession":"0001012975-16-001495","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-16-001495","line_url":"/filing/0001012975-16-001495","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"KANIA EDWIN M JR; AFEYAN NOUBAR; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund 2007, L.P.; Flagship Ventures Fund IV-Rx, L.P.","owner_display_name":"KANIA EDWIN M JR","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35770.0,"shares_display":"35,770","price_per_share":4.63,"price_display":"4.63","price_state":"stated","total_value":165615.1,"total_display":"165,615.10","total_whole":"165,615","shares_owned_after":1886787.0,"shares_owned_after_display":"1,886,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-06","filed_date":"2016-09-08","scope":"insider","n_lines":3},{"id":2906690,"accession":"0001104659-16-131412","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001104659-16-131412","line_url":"/filing/0001104659-16-131412","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund IV, L.P.; Flagship Ventures Fund IV General Partner LLC; KANIA EDWIN M JR; AFEYAN NOUBAR; Flagship VentureLabs IV, LLC; Flagship Ventures Fund IV-Rx, L.P.","owner_display_name":"Flagship Ventures Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":3674660.0,"shares_owned_after_display":"3,674,660","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-07-06","filed_date":"2016-07-07","scope":"insider","n_lines":2},{"id":3109103,"accession":"0001012975-16-001264","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001012975-16-001264","line_url":"/filing/0001012975-16-001264","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Seres Therapeutics, Inc.","issuer_ticker":"MCRB","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Fund 2007, L.P.; Flagship Ventures Fund IV-Rx, L.P.; AFEYAN NOUBAR; Flagship VentureLabs IV, LLC; Flagship Ventures Fund IV, L.P.; Flagship Ventures 2007 General Partner LLC; Flagship Ventures Fund IV General Partner LLC; KANIA EDWIN M JR","owner_display_name":"Flagship Ventures Fund 2007, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":27.6,"price_display":"27.60","price_state":"stated","total_value":27600000.0,"total_display":"27,600,000.00","total_whole":"27,600,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-25","filed_date":"2016-05-27","scope":"insider","n_lines":3},{"id":6323602,"accession":"0001209191-14-078009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-078009","line_url":"/filing/0001209191-14-078009","is_derivative":false,"issuer_cik":"0001255927","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001255927","owner_cik":"0001255927","owner_name":"KANIA EDWIN M JR","owner_display_name":"KANIA EDWIN M JR","owner_url":"/insider/0001255927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54350.0,"shares_display":"54,350","price_per_share":38.0,"price_display":"38.00","price_state":"stated","total_value":2065300.0,"total_display":"2,065,300.00","total_whole":"2,065,300","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-23","filed_date":"2014-12-29","scope":"insider","n_lines":2},{"id":6786882,"accession":"0001181431-14-038645","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-14-038645","line_url":"/filing/0001181431-14-038645","is_derivative":false,"issuer_cik":"0001255927","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001255927","owner_cik":"0001255927","owner_name":"KANIA EDWIN M JR","owner_display_name":"KANIA EDWIN M JR","owner_url":"/insider/0001255927","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":387580.0,"shares_display":"387,580","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":116274.0,"total_display":"116,274.00","total_whole":"116,274","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-11","scope":"insider","n_lines":2},{"id":6786873,"accession":"0001181431-14-038645","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-038645","line_url":"/filing/0001181431-14-038645","is_derivative":false,"issuer_cik":"0001255927","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001255927","owner_cik":"0001255927","owner_name":"KANIA EDWIN M JR","owner_display_name":"KANIA EDWIN M JR","owner_url":"/insider/0001255927","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114720.0,"shares_display":"114,720","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":36710.4,"total_display":"36,710.40","total_whole":"36,710","shares_owned_after":369112.0,"shares_owned_after_display":"369,112","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-11","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2014-12-10|6786871","ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001756262","name":"TransMedics Group, Inc.","url":"/issuer/0001756262","role":"Director","n_filings":2,"first_seen":"2019-05-06","last_seen":"2021-11-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001682852","name":"Moderna, Inc.","url":"/issuer/0001682852","role":"Ten percent owner","n_filings":3,"first_seen":"2019-12-11","last_seen":"2020-01-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001633070","name":"Axcella Health Inc.","url":"/issuer/0001633070","role":"Ten percent owner","n_filings":1,"first_seen":"2019-05-15","last_seen":"2019-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001694665","name":"Evelo Biosciences, Inc.","url":"/issuer/0001694665","role":"Ten percent owner","n_filings":1,"first_seen":"2018-05-15","last_seen":"2018-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001453687","name":"SELECTA BIOSCIENCES INC","url":"/issuer/0001453687","role":"Director","n_filings":1,"first_seen":"2017-05-16","last_seen":"2017-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001485003","name":"Eleven Biotherapeutics, Inc.","url":"/issuer/0001485003","role":"Ten percent owner","n_filings":5,"first_seen":"2014-02-13","last_seen":"2016-09-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001556263","name":"Syros Pharmaceuticals, Inc.","url":"/issuer/0001556263","role":"Ten percent owner","n_filings":1,"first_seen":"2016-07-07","last_seen":"2016-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001609809","name":"Seres Therapeutics, Inc.","url":"/issuer/0001609809","role":"Ten percent owner","n_filings":1,"first_seen":"2016-05-27","last_seen":"2016-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001280600","name":"ACCELERON PHARMA INC","url":"/issuer/0001280600","role":"Director","n_filings":3,"first_seen":"2014-04-24","last_seen":"2014-12-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001407038","name":"BG Medicine, Inc.","url":"/issuer/0001407038","role":"Ten percent owner","n_filings":9,"first_seen":"2011-02-11","last_seen":"2014-12-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001463729","name":"Receptos, Inc.","url":"/issuer/0001463729","role":"Ten percent owner","n_filings":2,"first_seen":"2013-05-14","last_seen":"2013-11-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001385228","name":"BIND Therapeutics, Inc","url":"/issuer/0001385228","role":"Ten percent owner","n_filings":1,"first_seen":"2013-09-27","last_seen":"2013-09-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001373707","name":"TETRAPHASE PHARMACEUTICALS INC","url":"/issuer/0001373707","role":"Ten percent owner","n_filings":1,"first_seen":"2013-03-27","last_seen":"2013-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001274563","name":"HELICOS BIOSCIENCES CORP","url":"/issuer/0001274563","role":"Ten percent owner","n_filings":3,"first_seen":"2007-05-31","last_seen":"2009-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000886235","name":"ASPECT MEDICAL SYSTEMS INC","url":"/issuer/0000886235","role":"Director","n_filings":6,"first_seen":"2004-12-06","last_seen":"2004-12-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001255927","retrieved_at":"2026-08-25T18:34:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}